(Q40541603)

21 September 2017

1 reference

title

Teicoplanin or vancomycin in the treatment of gram-positive infections? (English)

1 reference

21 September 2017

main subject

gram-positive bacteria

0 references

1 reference

Murphy S

1

1 reference

21 September 2017

Pinney RJ

series ordinal

2

1 reference

21 September 2017

publication date

1 February 1995

1 reference

Journal of Clinical Pharmacy and Therapeutics

21 September 2017

published in

1 reference

21 September 2017

volume

20

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

5-11

1 reference

Teicoplanin metabolism in humans

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Structure and mechanism of action of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

The structure and mode of action of glycopeptide antibiotics of the vancomycin group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Anaerobic vaginosis: therapeutic and epidemiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Activity of teicoplanin against gram-negative anaerobes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Antibacterial activities and modes of action of vancomycin and related glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Structure, biochemistry and mechanism of action of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Mode of action and in-vitro activity of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

In vitro activity of teichomycin compared with those of other antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Mechanism of uptake of deglucoteicoplanin amide derivatives across outer membranes of Escherichia coli and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Novel membrane proteins present in teicoplanin-resistant, vancomycin sensitive, coagulase-negative Staphylococcus spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Emergence of vancomycin resistance in coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Resistance of enterococci to glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Vancomycin resistance in south London

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Treatment of antibiotic-associated colitis with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Oral vancomycin for antibiotic-associated pseudomembranous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Pharmacokinetics of vancomycin in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Vancomycin pharmacokinetics in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Serum protein-binding characteristics of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Pharmacokinetics of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

The Garrod lecture. Progress in understanding urinary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

In vitro activity and human pharmacokinetics of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Pharmacokinetics of teicoplanin in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

The role of Gram-positive therapy in the neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Vancomycin- and erythromycin-induced hearing loss in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Vancomycin toxicity: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Vancomycin and the red-man syndrome: pharmacodynamics of histamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Prophylaxis, cost and effectiveness of therapy of infections caused by Gram-positive organisms in neutropenic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

Cost of hospital antimicrobial chemotherapy. A method for global cost calculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1995.TB00619.X

10.1111/J.1365-2710.1995.TB00619.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference